Fountain Life.

The thesis

Fountain Life was built on a single editorial bet: that the most important medical event of your next decade is a finding you don’t yet have, that imaging and genomics can surface earlier than symptoms, and that a network of well-resourced clinics can detect it. We agree with the thesis. The execution is, in 2026, among the most technologically capable in the United States.

The Naples founding clinic, plus Orlando, Dallas, Westchester (NY), and now Houston, run a Precision Diagnostics workup at $11,700: whole-body MRI with AI-augmented reading, cardiac AI imaging, whole-genome sequencing, 200+ biomarkers, DEXA, VO₂ max, multi-cancer detection. The technology stack is genuinely state-of-the-art. The clinicians are real.

What you get

The detection day is rigorous. Three things stand out from the workups we’ve audited.

The cardiac imaging is unusually deep — CT calcium plus functional imaging plus AI-augmented coronary reading. For a US-based reader with cardiac family history, this is meaningfully more than the typical executive physical produces.

The MRI reading benefits from the AI augmentation in a way the marketing implies and the clinical practice substantiates: incidental findings are flagged and triaged faster than at the typical hospital radiology desk.

The genomic component is real whole-genome sequencing, not a SNP chip — which most longevity clinics quietly substitute for the headline service.

The conflict question

Where Fountain Life loses points relative to YEARS or Biograph: the financial geometry of the APEX membership.

After Precision Diagnostics, the natural next step the clinic offers — and which the marketing structure encourages — is the $19,500/year APEX membership. APEX is real concierge medicine: ongoing care team, year-round follow-up, protocol design, hormone optimisation where indicated. Some locations include hyperbaric oxygen, targeted regenerative protocols (described as emerging), and IV infusions in the membership ladder.

This is the structural pattern we deduct points for. The clinic that ran the workup is also the clinic billing for the year of treatments downstream. The arrangement is not unusual in American medicine — it is, in fact, the executive-medicine norm — but it sits in tension with editorial independence on what a finding actually warrants.

We score the diagnostic strongly. We score the conflict structure honestly.

Where it falls short

Three honest caveats.

The regenerative and stem-cell-adjacent treatments offered at certain locations sit in evidence territory we believe deserves stronger labelling than the current marketing provides. The clinicians in conversation are appropriately conservative; the website is less so.

The aggregate cost of Precision Diagnostics plus an APEX year is around $31,000 — comparable to a Swiss residential week, with a different value proposition. We are not sure the comparison consistently favours Fountain Life.

The brand voice — Diamandis, Robbins, abundance — runs warmer than the editorial tone the field arguably needs. We mention this because we have heard it from readers.

The verdict

For the US-based reader who wants a state-of-the-art detection day under a single well-resourced roof, Fountain Life is the strongest network option we currently rank. Where it does not lead — and where YEARS and Biograph do — is on the question of what business model the diagnostic feeds into.

Detection is hard, expensive, and worth doing well. Selling treatments to the patient you just detected is also hard, but for different reasons.